Inhibition of Histone Lysine-specific Demethylase 1 Elicits Breast Tumor Immunity and Enhances Antitumor Efficacy of Immune Checkpoint Blockade

Immunotherapy strategies have been emerging as powerful weapons against cancer. Early clinical trials reveal that overall response to immunotherapy is low in breast cancer patients, suggesting that effective strategies to overcome resistance to immunotherapy are urgently needed. In this study, we in...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncogene
Hlavní autoři: Qin, Ye, Vasilatos, Shauna N., Chen, Lin, Wu, Hao, Cao, Zhishen, Fu, Yumei, Huang, Min, Vlad, Anda M., Lu, Binfeng, Oesterreich, Steffi, Davidson, Nancy E., Huang, Yi
Médium: Artigo
Jazyk:Inglês
Vydáno: 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6336685/
https://ncbi.nlm.nih.gov/pubmed/30111819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-018-0451-5
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky